FR2838969B1 - Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues - Google Patents

Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues

Info

Publication number
FR2838969B1
FR2838969B1 FR0205458A FR0205458A FR2838969B1 FR 2838969 B1 FR2838969 B1 FR 2838969B1 FR 0205458 A FR0205458 A FR 0205458A FR 0205458 A FR0205458 A FR 0205458A FR 2838969 B1 FR2838969 B1 FR 2838969B1
Authority
FR
France
Prior art keywords
compositions
nanodispersee
micro
pressure sterilization
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0205458A
Other languages
English (en)
Other versions
FR2838969A1 (fr
Inventor
Luc Grislain
Gerard Demazeau
Alain Largeteau
Yohan Rigaldie
Patrick Couvreur
Guilbert Irene Brigger
Rene Laversanne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ellipse Pharmaceuticals SAS
Original Assignee
Ellipse Pharmaceuticals SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellipse Pharmaceuticals SAS filed Critical Ellipse Pharmaceuticals SAS
Priority to FR0205458A priority Critical patent/FR2838969B1/fr
Publication of FR2838969A1 publication Critical patent/FR2838969A1/fr
Application granted granted Critical
Publication of FR2838969B1 publication Critical patent/FR2838969B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
FR0205458A 2002-04-30 2002-04-30 Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues Expired - Fee Related FR2838969B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0205458A FR2838969B1 (fr) 2002-04-30 2002-04-30 Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0205458A FR2838969B1 (fr) 2002-04-30 2002-04-30 Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues

Publications (2)

Publication Number Publication Date
FR2838969A1 FR2838969A1 (fr) 2003-10-31
FR2838969B1 true FR2838969B1 (fr) 2006-05-19

Family

ID=28800092

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0205458A Expired - Fee Related FR2838969B1 (fr) 2002-04-30 2002-04-30 Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues

Country Status (1)

Country Link
FR (1) FR2838969B1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461349C (fr) 2001-09-26 2011-11-29 Baxter International Inc. Preparation de nanoparticules submicroniques par dispersion et elimination d'un solvant ou d'une phase liquide
ES2394208T3 (es) 2003-09-22 2013-01-23 Baxter International Inc. Esterilización a alta presión para la esterilización definitiva de preparaciones farmacéuticas y productos médicos
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
DE19905159A1 (de) * 1999-02-08 2000-08-10 Gerrit Hoehn Verfahren zur Sterilisation und Zerstörung unerwünschter Substanzen auf Operationsbestecken, Nahtmaterial, Zubehör für die Analytik, Implantaten mit Medikamentenzugabe und Medikamenten
FR2804326B1 (fr) * 2000-01-27 2002-10-18 Ellipse Pharmaceuticals Procede de sterilisation par traitement sous hautes pressions de principes actifs sensibles

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol

Also Published As

Publication number Publication date
FR2838969A1 (fr) 2003-10-31

Similar Documents

Publication Publication Date Title
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
IL157656A (en) Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
EE04590B1 (et) Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende kasutamine ja valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt
NO20085338L (no) Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav
NO20030724D0 (no) Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
ATE293978T1 (de) Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
WO2005020928A3 (fr) Agents et procedes permettant d'ameliorer la formation osseuse a l'aide d'oxysterols combines a des proteines morphogeniques osseuses
WO2005027977A3 (fr) Compositions de diclofenac destinees au traitement d'affections cutanees
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
NO20055367L (no) Kombinasjoner som innbefatter paroksetin og 2-(S)-4-fluor-2-metyl-fenyl)-piperazin-1-karboksylsyer (1-(R)-(3,5-bis-trifluor-2-metyl-fenyl)-etyl]metylamid for behandling av depresjon og/eller angst
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
WO2005034889A3 (fr) Methode pour conferer un hale artificiel a la peau humaine
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
FR2838969B1 (fr) Procede de sterilisation par haute pression de compositions pharmaceutiques sous forme micro ou nanodispersee et compositions ainsi obtenues
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
WO2004006911A3 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121228